Kayentis, a global provider of electronic Clinical Outcome Assessment (eCOA) and Decentralized Clinical Trial (DCT) solutions, and Ametris (formerly ActiGraph), a gl...

Slope and LabConnect have announced significant momentum in their partnership following the 2025 launch of an API integration that connects Slope’s site-facing platf...

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of the CRF Creator module within its Pinnacle 21 Enterpr...

Cirena, pioneers in long and ultra-long, high purity RNA synthesis for gene editing and functional genomics, today announced its public launch following successful d...

Ardena, a specialist CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, today announced that it has completed the divestment of its...

Veeva Systems (NYSE: VEEV) today announced Veeva eSource, a new Veeva SiteVault application designed to significantly reduce manual clinical tria...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine leveraging SKYCovione’s recombinant pro...

Epigenica AB announces the launch of its EpiFinder™ Analysis Service, a fully managed, high-throughput platform designed to make advanced epigenomic research faster,...

Openwater, an open-source medical technology company delivering portable, hospital-grade diagnostic and therapeutic research devices, today announced that c Menta...

Astoriom, a global leader in scientific research and consumer product sample stability and biorepository storage, has expanded its sample management capabilities in ...